... Targeted therapy drugs are most often used to treat advanced kidney cancer, but they may be helpful as an adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus ...
8 Kidney Cancer Treatments: Surgery, Immunotherapy, Targeted Therapy, and More
... Targeted therapy drugs are most often used to treat advanced kidney cancer, but they may be helpful as an adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus ...
... If they stop working, you may receive cabozantinib or axitinib next.Bevacizumab (Avastin) is a medication that blocks new blood vessel growth. It’s given as an infusion through a vein (IV) every two weeks.Inhibitors of mTORMammalian target of rapamycin (mTOR) inhibitors block the mTOR protein, which cancer cells use to grow and divide. ...
Metastatic Kidney Cancer: Symptoms and Treatment Options
... If they stop working, you may receive cabozantinib or axitinib next.Bevacizumab (Avastin) is a medication that blocks new blood vessel growth. It’s given as an infusion through a vein (IV) every two weeks.Inhibitors of mTORMammalian target of rapamycin (mTOR) inhibitors block the mTOR protein, which cancer cells use to grow and divide. ...